BluMaiden
Latest round
- Seed
Last raised
- Jan 2023
Total raised
- $2M
Investors
- 3
About BluMaiden
Founded in 2020 and based in Singapore, BluMaiden is a biotechnology firm that develops illness therapeutics based on the microbiome. As of 2022, Damien Keogh is the CEO of the company. The company provides science and technologies including data capture, database, data analytics, and drug discovery. The firm offers services including consumer genomics and digital health, clinical studies, research partnerships, therapeutics, and diagnostics. BluMaiden is developing diagnostics and therapeutics by leveraging DNA sequencing, AI-powered analytics, population-scale precision health data, and novel drug development tools.
Who invested in BluMaiden
3 investors across 2 rounds
See all investors in BluMaiden
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BluMaiden
Who invested in BluMaiden?
BluMaiden has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BluMaiden raised?
BluMaiden has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did BluMaiden last raise money?
BluMaiden's most recent round on record is a Seed, in Jan 2023.
What does BluMaiden do?
Founded in 2020 and based in Singapore, BluMaiden is a biotechnology firm that develops illness therapeutics based on the microbiome.
Where is BluMaiden headquartered?
BluMaiden is headquartered in Singapore, Singapore.
Which VCs invest in companies like BluMaiden?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at BluMaiden's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like BluMaiden? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.